Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?

  1. Araujo-Castro, M.
  2. Hanzu, F.A.
  3. Pascual-Corrales, E.
  4. García Cano, A.M.
  5. Marchan, M.
  6. Escobar-Morreale, H.F.
  7. Valderrabano, P.
  8. Casals, G.
Journal:
Endocrine

ISSN: 1559-0100 1355-008X

Year of publication: 2023

Volume: 82

Issue: 1

Pages: 161-170

Type: Article

DOI: 10.1007/S12020-023-03429-0 GOOGLE SCHOLAR

Sustainable development goals